This uncertainty is why personalized medical supervision is critical and why PlexusDx emphasizes coordination with gastroenterology specialists
Direct answer: Employer plans often deny semaglutide for weight loss because many employers choose not to include anti-obesity drugs as a benefit
In the US, GLP-1s such as Ozempic now account for over 7% of all prescriptions, indicating a significant change in the treatment of obesity
Semaglutide, also known by the brand names Ozempic, Wegovy, and Rybelsus, is a medication approved by the Food and Drug Administration (FDA)
Before making any changes, however, you should talk with your healthcare provider to discuss the pros and cons of each specific medication
The WW program changed over the years from only eat these foods to the point system